PSTV: Plus Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Plus Therapeutics Inc (PSTV).
$6.78M Market Cap.
PSTV Market Cap. (MRY)
PSTV Shares Outstanding (MRY)
PSTV Assets (MRY)
Total Assets
$6.63M
Total Liabilities
$15.58M
Total Investments
$3.53M
PSTV Income (MRY)
Revenue
$5.82M
Net Income
-$12.98M
Operating Expense
$20.52M
PSTV Cash Flow (MRY)
CF Operations
-$10.55M
CF Investing
-$4.11M
CF Financing
$6.19M
PSTV Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $6,633,000 (-41.75%) | $11,388,000 (-52.29%) | $23,867,000 (8.58%) | $21,981,000 (81.59%) |
Assets Current | $5,259,000 (-46.52%) | $9,834,000 (-54.93%) | $21,817,000 (10.61%) | $19,724,000 (114.98%) |
Assets Non-Current | $1,374,000 (-11.58%) | $1,554,000 (-24.20%) | $2,050,000 (-9.17%) | $2,257,000 (-22.97%) |
Goodwill & Intangible Assets | $841,000 (103.14%) | $414,000 (-11.16%) | $466,000 (10.17%) | $423,000 (-7.64%) |
Shareholders Equity | -$8,949,000 (-563.87%) | -$1,348,000 (-120.92%) | $6,445,000 (-40.52%) | $10,836,000 (257.51%) |
Property Plant & Equipment Net | $521,000 (-52.98%) | $1,108,000 (-29.52%) | $1,572,000 (-13.53%) | $1,818,000 (-25.98%) |
Cash & Equivalents | $76,000 (-99.11%) | $8,554,000 (-52.79%) | $18,120,000 (-1.52%) | $18,400,000 (120.46%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $3,530,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $3,530,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $571,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $11,288,000 (70.23%) | $6,631,000 (-34.57%) | $10,134,000 (144.13%) | $4,151,000 (99.47%) |
Accumulated Retained Earnings (Deficit) | -$493,479,000 (-2.70%) | -$480,501,000 (-2.85%) | -$467,185,000 (-4.54%) | -$446,910,000 (-3.09%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $3,367,000 (-19.47%) | $4,181,000 (-25.93%) | $5,645,000 (-19.28%) | $6,993,000 (0.10%) |
Debt Current | $3,336,000 (-18.55%) | $4,096,000 (138.42%) | $1,718,000 (-0.06%) | $1,719,000 (-73.38%) |
Debt Non-Current | $31,000 (-63.53%) | $85,000 (-97.84%) | $3,927,000 (-25.54%) | $5,274,000 (898.86%) |
Total Liabilities | $15,582,000 (22.35%) | $12,736,000 (-26.90%) | $17,422,000 (56.32%) | $11,145,000 (22.82%) |
Liabilities Current | $15,551,000 (44.97%) | $10,727,000 (-9.49%) | $11,852,000 (101.91%) | $5,870,000 (-31.26%) |
Liabilities Non-Current | $31,000 (-98.46%) | $2,009,000 (-63.93%) | $5,570,000 (5.59%) | $5,275,000 (885.98%) |
PSTV Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $5,824,000 (18.54%) | $4,913,000 (2093.30%) | $224,000 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $9,939,000 (16.33%) | $8,544,000 (-16.55%) | $10,238,000 (49.39%) | $6,853,000 (6.98%) |
Research & Development Expense | $10,580,000 (9.18%) | $9,690,000 (-0.08%) | $9,698,000 (82.19%) | $5,323,000 (97.15%) |
Operating Expenses | $20,519,000 (12.53%) | $18,234,000 (-8.54%) | $19,936,000 (59.59%) | $12,492,000 (26.35%) |
Interest Expense | $3,724,000 (842.78%) | $395,000 (-44.44%) | $711,000 (-23.71%) | $932,000 (-15.81%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$12,978,000 (2.54%) | -$13,316,000 (34.32%) | -$20,275,000 (-51.32%) | -$13,399,000 (-62.59%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$12,978,000 (2.54%) | -$13,316,000 (34.32%) | -$20,275,000 (-51.32%) | -$13,399,000 (-62.59%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$12,978,000 (2.54%) | -$13,316,000 (34.32%) | -$20,275,000 (-51.32%) | -$13,399,000 (-62.59%) |
Weighted Average Shares | $6,640,251 (111.41%) | $3,140,925 (79.45%) | $1,750,350 (117.07%) | $806,349 (173.03%) |
Weighted Average Shares Diluted | $7,700,774 (145.18%) | $3,140,925 (79.45%) | $1,750,350 (117.07%) | $806,349 (173.03%) |
Earning Before Interest & Taxes (EBIT) | -$9,254,000 (28.38%) | -$12,921,000 (33.96%) | -$19,564,000 (-56.93%) | -$12,467,000 (-74.75%) |
Gross Profit | $5,824,000 (18.54%) | $4,913,000 (2093.30%) | $224,000 (0%) | $0 (0%) |
Operating Income | -$14,695,000 (-10.31%) | -$13,321,000 (32.42%) | -$19,712,000 (-57.80%) | -$12,492,000 (-30.34%) |
PSTV Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$4,111,000 (-2469.38%) | -$160,000 (78.92%) | -$759,000 (-825.61%) | -$82,000 (83.37%) |
Net Cash Flow from Financing | $6,187,000 (79.59%) | $3,445,000 (-74.39%) | $13,451,000 (-34.12%) | $20,416,000 (6500.00%) |
Net Cash Flow from Operations | -$10,554,000 (17.87%) | -$12,851,000 (0.93%) | -$12,972,000 (-26.19%) | -$10,280,000 (-21.89%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$8,478,000 (11.37%) | -$9,566,000 (-3316.43%) | -$280,000 (-102.78%) | $10,054,000 (208.74%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$3,420,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$146,000 (8.75%) | -$160,000 (68.57%) | -$509,000 (-520.73%) | -$82,000 (11.83%) |
Issuance (Repayment) of Debt Securities | -$704,000 (56.22%) | -$1,608,000 (0.00%) | -$1,608,000 (-482.61%) | -$276,000 (94.91%) |
Issuance (Purchase) of Equity Shares | $6,891,000 (27.59%) | $5,401,000 (-65.89%) | $15,832,000 (-23.49%) | $20,692,000 (305.33%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $550,000 (-3.34%) | $569,000 (-6.11%) | $606,000 (0.00%) | $606,000 (145.34%) |
Depreciation Amortization & Accretion | $852,000 (14.36%) | $745,000 (4.63%) | $712,000 (69.93%) | $419,000 (13.55%) |
PSTV Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% | - |
Profit Margin | -222.80% (17.79%) | -271.00% (97.01%) | -9051.30% | - |
EBITDA Margin | -144.30% (41.77%) | -247.80% (97.06%) | -8416.10% | - |
Return on Average Equity (ROAE) | 195.30% (124.24%) | -805.60% (-318.93%) | -192.30% (-68.83%) | -113.90% (68.78%) |
Return on Average Assets (ROAA) | -170.50% (-74.51%) | -97.70% (-11.78%) | -87.40% (-40.06%) | -62.40% (-11.03%) |
Return on Sales (ROS) | -158.90% (39.58%) | -263.00% (96.99%) | -8733.90% | - |
Return on Invested Capital (ROIC) | 150.40% (-51.09%) | 307.50% (125.73%) | -1195.30% (-129.47%) | -520.90% (-20.47%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.59 (-42.86%) | -0.41 (-0.73%) | -0.41 (56.66%) | -0.95 (12.89%) |
Price to Sales Ratio (P/S) | 1.31 (17.16%) | 1.12 (-96.99%) | 37.14 | - |
Price to Book Ratio (P/B) | -0.76 (87.09%) | -5.87 (-455.23%) | 1.65 (11.09%) | 1.49 (-53.28%) |
Debt to Equity Ratio (D/E) | -1.74 (81.57%) | -9.45 (-449.54%) | 2.7 (162.68%) | 1.03 (-65.63%) |
Earnings Per Share (EPS) | -1.95 (54.01%) | -4.24 (63.39%) | -11.58 (30.42%) | -16.64 (40.32%) |
Sales Per Share (SPS) | 0.88 (-43.93%) | 1.56 (1121.88%) | 0.13 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -1.61 (61.11%) | -4.14 (46.22%) | -7.7 (40.07%) | -12.85 (55.49%) |
Book Value Per Share (BVPS) | -1.35 (-214.22%) | -0.43 (-111.65%) | 3.68 (-72.60%) | 13.44 (30.94%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.87 (-75.04%) | 3.49 (-73.86%) | 13.37 (-49.99%) | 26.73 (-32.21%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.07 (-766.67%) | -0.12 (-164.06%) | 0.19 (204.92%) | -0.18 (86.08%) |
Asset Turnover | 0.77 (111.91%) | 0.36 (3510.00%) | 0.01 (0%) | 0 (0%) |
Current Ratio | 0.34 (-63.14%) | 0.92 (-50.19%) | 1.84 (-45.21%) | 3.36 (212.85%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$10,700,000 (17.76%) | -$13,011,000 (3.49%) | -$13,481,000 (-30.10%) | -$10,362,000 (-21.52%) |
Enterprise Value (EV) | $8,957,783 (500.35%) | $1,492,100 (141.23%) | -$3,619,365 (-263.77%) | $2,210,026 (-75.15%) |
Earnings Before Tax (EBT) | -$12,978,000 (2.54%) | -$13,316,000 (34.32%) | -$20,275,000 (-51.32%) | -$13,399,000 (-62.59%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$8,402,000 (31.00%) | -$12,176,000 (35.41%) | -$18,852,000 (-56.47%) | -$12,048,000 (-78.09%) |
Invested Capital | -$6,468,000 (-56.76%) | -$4,126,000 (-345.57%) | -$926,000 (-121.63%) | $4,281,000 (144.91%) |
Working Capital | -$10,292,000 (-1052.52%) | -$893,000 (-108.96%) | $9,965,000 (-28.07%) | $13,854,000 (2078.30%) |
Tangible Asset Value | $5,792,000 (-47.22%) | $10,974,000 (-53.10%) | $23,401,000 (8.55%) | $21,558,000 (85.09%) |
Market Capitalization | $6,780,783 (-14.33%) | $7,915,100 (-25.69%) | $10,651,635 (-33.96%) | $16,128,026 (67.05%) |
Average Equity | -$6,646,250 (-502.07%) | $1,653,000 (-84.32%) | $10,542,500 (-10.37%) | $11,762,250 (420.63%) |
Average Assets | $7,611,000 (-44.14%) | $13,625,250 (-41.24%) | $23,189,500 (7.98%) | $21,475,250 (46.52%) |
Invested Capital Average | -$6,153,000 (-46.41%) | -$4,202,500 (-356.76%) | $1,636,750 (-31.61%) | $2,393,250 (45.05%) |
Shares | 5,896,333 (30.37%) | 4,522,656 (101.80%) | 2,241,212 (118.76%) | 1,024,514 (221.37%) |
